OHSU in the news

Melanoma management forges a new path

American Academy of Dermatology December 01, 2023
In an American Academy of Dermatology article on a promising new model for melanoma treatment in the form of a personalized vaccine, Elizabeth Berry, M.D., says: “This is an exciting, groundbreaking time. We’ve known for decades that melanoma is immunogenic, and the Holy Grail has been to develop some sort of vaccine against melanoma. Researchers have been trying to do this for decades, and it has not been successful until now.”

OHSU Leads Telehealth Study For AIDS Treatment

KBND Radio December 01, 2023
Christopher Fox, M.S.N., RN, is leading a two-year study to evaluate health outcomes for 125 patients who receive treatment through the OHSU Tele-PreP Program, which seeks to improve patient access to highly effective, HIV-preventing medications. Fox says, “People who have an increased risk for HIV also often face challenges accessing health care, and some health care providers don’t prescribe PrEP because they mistakenly assume a patient doesn’t need it. Telemedicine — which enables patients to receive health care from the comfort and safety of their own homes — can help overcome these barriers.”

Novel Subcutaneous Biologics Show Promise in Atopic Dermatitis

Medscape December 01, 2023
Two novel monoclonal antibody therapies appear to have a significant impact on disease severity in patients with moderate to severe atopic dermatitis. Eric Simpson, M.D., says “The speed of onset was rapid, with clinical improvements seen as early as week two.”

Clinical Challenges: Current Treatment for Axial Spondyloarthritis

MedPage Today December 01, 2023
Atul Deodhar, M.D., discusses current treatments for axial spondyloarthritis, including tumor necrosis factor inhibitors: “For many years we only had physical therapy and NSAIDS, but we now have better drugs like biologics that I truly believe have changed the course of disease.”

How to tell if someone is high on drugs — and what you can do to help

New York Post December 01, 2023
Emily Skogrand, Pharm.D., shares considerations for increased alcohol consumption around the holidays: “With alcohol, any of the depressants, any opiates, any barbiturates or benzodiazepines, can be very dangerous. The risk of harm is so much greater.”

OHSU study finds falling injuries are on the rise, seeks to reduce risk

KOIN-TV December 01, 2023
Katie Drago, M.D., notes the most common cause of trauma injuries at OHSU is falling, and 75% of those falls tend to happen with people over the age of 65: “Falling is not a normal part of aging — it is not inevitable. There are lots of things people can do to reduce the risk.”

Pacific Heart, Lung & Blood Institute Is Dissolving

Asbestos.com December 01, 2023
The Pacific Heart, Lung & Blood Institute in California is closing and donating its equipment and funding to UCLA and the OHSU Knight Cancer Institute. PHLBI Executive Director Clare Cameron says the organization is closely working with leaders at both universities to ensure the transition is handled properly.

Everything you need to know about external cephalic version

Romper November 30, 2023
Michele Megregian, Ph.D., shares insight on options for delivery when a baby is breech, including a procedure called external cephalic version. Megregian says, “We listen to the pregnant person's instinct about their own bodies, too. Some people who go into this with the attitude that the baby is breech for a reason, and so we explore that pregnant person's feelings around that framework and we support them.”
See more stories